$172.4 Million
Tourmaline Bio
Tourmaline Bio
Confidentially Marketed Follow-On Offering
Active Bookrunner
$201.5 Million
New Amsterdam Pharma N.V.
New Amsterdam Pharma N.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$1.1 Billion
Applovin
Applovin
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$75.0 Million
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$600.0 Million
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$200.0 Million
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$166.7 Million
Squarespace
Squarespace, Inc.
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$60.0 Million
Inozyme
Inozyme Pharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.0 Million
BlackDiamond
Black Diamond Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner
$22.8 Million
Gamida
Gamida Cell Ltd.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Subscribe to CMFO

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.